Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Endpoints News
endpoints.news > superluminal-secures-60m-for-phase-1-of-genetic-obesity-drug

Superluminal secures $60M for Phase 1 of genetic obesity drug

3+ hour, 38+ min ago   (82+ words) Endpoints News Su­per­lu­mi­nal se­cures $60M for Phase 1 of ge­net­ic obe­si­ty drug A Boston biotech fol­low­ing in the foot­steps of Rhythm Phar­ma­ceu­ti­cals and oth­ers in…...